|
|
||||||||
1 The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, Pennsylvania 19140; 2 Center for Gastrointestinal Biology and Disease, Departments of Medicine, Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina 27599; and 3 Department of Pharmacy, University of Montreal, Montreal, Quebec H3C 3J7, Canada
Genetically susceptible Lewis rats injected in the intestinal wall with peptidoglycan-polysaccharide (PG-APS) polymers develop chronic granulomatous enterocolitis concomitant with activation of the kallikrein-kinin system. To elucidate the role of high-molecular-weight kininogen (HK) in chronic enterocolitis, we back crossed Brown-Norway rats having a HK deficiency with Lewis rats for five generations. Two new strains were produced, wild-type F5 (F5WT) and HK deficient (F5HKd), each with a ~97% Lewis genome. The HK values of F5WT and F5HKd rat plasma were 0.62 ± 0.20 and 0.08 ± 0.03 U/ml, respectively. In PG-APS-injected rats, chronic inflammation was measured by using gross gut score, histological inflammation, liver granuloma, and white blood cell count. The mean gross gut scores were significantly lower in the F5HKd than in the F5WT rats. Plasma T-kininogen was significantly less in F5HKd. These results indicate the importance of the kallikrein-kinin system in this model of chronic enterocolitis and systemic inflammation.
inflammatory bowel disease; experimental colitis; kallikrein-kinin system; contact system
This article has been cited by other articles:
![]() |
V. Perez, V. Velarde, C. Acuna-Castillo, C. Gomez, S. Nishimura, V. Sabaj, R. Walter, and F. Sierra Increased Kinin Levels and Decreased Responsiveness to Kinins During Aging J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2005; 60(8): 984 - 990. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stadnicki, E. Pastucha, G. Nowaczyk, U. Mazurek, D. Plewka, G. Machnik, T. Wilczok, and R. W. Colman Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease Am J Physiol Gastrointest Liver Physiol, August 1, 2005; 289(2): G361 - G366. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Isordia-Salas, R. A. Pixley, H. Parekh, S. P. Kunapuli, F. Li, A. Stadnicki, Y. Lin, R. B. Sartor, and R. W. Colman The mutation Ser511Asn leads to N-glycosylation and increases the cleavage of high molecular weight kininogen in rats genetically susceptible to inflammation Blood, October 15, 2003; 102(8): 2835 - 2842. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |